The findings of this retrospective study suggest that non-linear aspheric micro-monovision LASIK can achieve safe and effective correction of myopic and hyperopic presbyopia with high patient satisfaction up to one year postoperatively.
Abstract
Purpose To investigate clinical outcomes and satisfaction following non-linear aspheric micro-monovision LASIK for presbyopia. Patients and Methods Retrospective single-center study of myopic and hyperopic presbyopic patients treated with LASIK-induced micro-monovision combined with non-linear aspheric ablation profiles (PRESBYOND® Laser Blended Vision, Carl Zeiss Meditec AG) at Optegra Eye Clinic, Poland, between January 2019 and December 2023. Dominant eyes were targeted for plano; non-dominant eyes were targeted for −0.40 to −2.00 diopters (D). Visual acuity (VA) was assessed at 1, 3, and 12 months. Patients completed a purpose-made (non-validated) questionnaire assessing subjective experience and satisfaction at 3–6 months and 12 months postoperatively. Results The study included 638 eyes of 319 patients (442 myopic eyes and 196 hyperopic eyes). At 12 months, binocular uncorrected distance VA was 20/20 or better in 98% of myopic patients and 93% of hyperopic patients. Binocular uncorrected near VA was N6 or better in 99% of myopic patients and 96% of hyperopic patients. All eyes were within ±1.00 D of intended spherical equivalent in both groups. No eyes in the myopia group and one eye in the hyperopia group lost two or more lines of corrected distance VA. Seventy out of 100 respondents at the 12-month visit (70%) experienced an improvement in vision within hours to a few days. Vision quality was rated satisfactory to excellent by 92% of patients and 89% were happy with the procedure. Conclusion The findings of this retrospective study suggest that non-linear aspheric micro-monovision LASIK can achieve safe and effective correction of myopic and hyperopic presbyopia with high patient satisfaction up to one year postoperatively. Prospective studies using validated questionnaires are required to further characterize patient-reported outcomes with this procedure.
Purpose To compare the clinical and patient-reported outcomes following bilateral implantation of partial-depth-of-field enhanced monofocal IOL in subjects achieving bilateral emmetropia vs mini-monovision. Patients and Methods This prospective, non-interventional, multicenter, cross-sectional study included subjects w...
J. G. Parekh, Christopher M. Spearman, J. Micheletti et al.· Clinical Ophthalmology· 0 citations
PURPOSE
To determine the optimal myopic target refraction for enhanced monofocal IOL implantation in highly myopic cataract patients.
METHODS
A retrospective comparative study was conducted in Zhongshan Ophthalmic Center, China. Cataract patients with axial length (AL) ≥ 26 mm who underwent phacoemulsification with e...
Dan-Yue Chen, Hao-Wen Lin, Xiao-Hang Xie et al.· Graefe's archive for clinica...· 0 citations
Purpose To evaluate 12-month visual and clinical outcomes after implantation of a monofocal aspheric hydrophobic acrylic intraocular lens (IOL) delivered with a preloaded system. Methods This investigator-initiated, prospective, single-center, uncontrolled feasibility study enrolled 30 patients undergoing unilateral or...
Oliver Hassel, M. K. Hallak, Max K Köppe et al.· Clinical Ophthalmology· 0 citations
Bilateral implantation of an enhanced monofocal IOL with targeted mini-monovision was associated with excellent visual outcomes at intermediate and distance vision with a high level of satisfaction.
Işıl Kefeli Kırcalı, U. Gunenc, C. A. Utine et al.· BMC Ophthalmology· 0 citations
To evaluate long-term (5-year) refractive and corneal tomographic changes induced by overnight orthokeratology (OK) in eyes with myopic regression after photorefractive keratectomy (PRK), with a focus on visual efficacy, mid-peripheral alignment-based lens-fitting methodology, and corneal safety. This single-center ret...
A. Rotondi, Claudia Stratta, C. Colandrea et al.· BMC Ophthalmology· 0 citations
In the initial experience with the WLP and SMILE Pro platforms, WLP achieved better UDVA and more precise astigmatic correction compared with SMILE Pro and had comparable safety and efficacy outcomes to WFO.
Sanjana Molleti, Hanna Pawlowski, Randle M. Uyeda et al.· Ophthalmology and Therapy· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.